Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rassool

Showing results (221-230 of 222) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 222 results.
The Lancet. Infectious Diseases|May 20, 2024
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trialMuge Cevik, Lindsay C Thompson, Caryn Upton, et al.
The European Physical Journal. C, Particles and Fields|September 26, 2017
Higgs physics at the CLIC electron-positron linear colliderH Abramowicz, A Abusleme, K Afanaciev, et al.
Pageof 23

Showing results (221-230 of 222) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 222 results.
The Lancet. Infectious Diseases|May 20, 2024
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trialMuge Cevik, Lindsay C Thompson, Caryn Upton, et al.
The European Physical Journal. C, Particles and Fields|September 26, 2017
Higgs physics at the CLIC electron-positron linear colliderH Abramowicz, A Abusleme, K Afanaciev, et al.
Pageof 23